Crestchem Limited has been penalized ₹1,06,200 by the Bombay Stock Exchange Limited (BSE) for failing to submit its consolidated cash flow statement within the prescribed timeline. The exchange notified the company of the outstanding fine via email on August 4, 2026, at 10:29 AM, citing a violation of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory action highlights compliance risks associated with complex group structures and tight reporting deadlines.

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations. While the BSE communicated the monetary penalty, Crestchem Limited stated that it had not yet received the formal order or direction detailing the imposition of the fine as of the date of the communication. The company is required to pay the outstanding amount to regularize its standing with the exchange.

The delay in filing stemmed from the incorporation of the company’s subsidiary, Oleo Biosciences Private Limited, on March 31, 2026, which was the final day of the financial year. Because the subsidiary was established on the balance sheet date, it had no financial transactions to report as of that date. Consequently, there was no financial data requiring inclusion in the consolidated cash flow statement for the subsidiary, which contributed to the administrative delay in the consolidated filing process.

Financial Impact Assessment

Despite the regulatory breach, Crestchem Limited clarified that the fine will not have a material financial impact on its operations or balance sheet. The management expressed confidence that the exchange may consider a waiver for the penalty given the specific circumstances surrounding the subsidiary’s incorporation. The company emphasized that the absence of transactional data from the newly formed entity meant the omission did not reflect any underlying financial distress or reporting gap in substantive terms.

Nitin S Shah, Company Secretary, Compliance Officer & CFO of Crestchem Limited, signed the disclosure on August 4, 2026. The company has requested the BSE to take the explanation and the pending payment status on record. Investors should note that while the monetary value is immaterial, consistent adherence to listing obligations remains critical for maintaining regulatory goodwill.

Crestchem Limited has fixed Thursday, July 31, 2026, as the record date to determine member entitlement for the final dividend for the financial year ended March 31, 2026. The 34th Annual General Meeting (AGM) of the company is scheduled to be held on Thursday, August 6, 2026, at 12:15 P.M. (IST) through Video Conferencing (VC) or Other Audio Visual Means (OAVM). The Register of Members and Share Transfer Books will remain closed from Wednesday, July 31, 2026, to Tuesday, August 6, 2026, for the purpose of the AGM.

Pursuant to the provisions of the Companies Act, 2013, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has appointed M/s. Rahul Mevada & Associates as the Scrutinizer to scrutinize the e-voting process. The facility for remote e-voting will be provided by Central Depository Services (India) Limited (CDSL). Shareholders holding shares in physical or dematerialized form as on the cut-off date of Thursday, July 31, 2026, will be eligible to cast their votes electronically.

Key Meeting Dates

The final dividend, if declared at the AGM, is proposed to be paid on and from Wednesday, August 12, 2026. Members who have not provided their bank details for electronic credit will receive dividend warrants or banker's cheques at their registered addresses. The Annual Report for FY 2025-26 has been sent via email to members registered with the company, its Registrar and Transfer Agent (RTA), or depositories.